KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.89 $4.97 Friday, 26th Apr 2024 ALDX stock ended at $3.93. This is 0.254% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.79% from a day low at $3.83 to a day high of $3.98.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Apr 28, 2023 $9.07 $9.63 $9.00 $9.53 538 979
Apr 27, 2023 $9.06 $9.44 $9.00 $9.05 910 454
Apr 26, 2023 $9.26 $9.23 $8.96 $9.07 627 554
Apr 25, 2023 $9.48 $9.54 $8.97 $9.08 1 067 698
Apr 24, 2023 $10.02 $10.11 $8.97 $9.45 2 174 292
Apr 21, 2023 $10.20 $10.35 $10.01 $10.02 949 394
Apr 20, 2023 $10.28 $10.47 $10.10 $10.20 594 037
Apr 19, 2023 $10.41 $10.48 $10.23 $10.34 582 472
Apr 18, 2023 $10.59 $10.80 $10.36 $10.49 1 589 619
Apr 17, 2023 $10.59 $10.66 $10.20 $10.39 561 880
Apr 14, 2023 $10.29 $10.52 $10.22 $10.44 511 765
Apr 13, 2023 $10.06 $10.89 $9.32 $10.32 2 155 391
Apr 12, 2023 $10.48 $10.64 $9.81 $9.97 1 263 664
Apr 11, 2023 $10.44 $10.81 $10.00 $10.39 2 898 668
Apr 10, 2023 $9.86 $10.33 $9.73 $10.33 936 095
Apr 06, 2023 $9.73 $9.95 $9.45 $9.89 848 088
Apr 05, 2023 $9.83 $9.87 $9.38 $9.73 832 726
Apr 04, 2023 $9.88 $10.00 $9.69 $9.92 999 841
Apr 03, 2023 $9.88 $10.03 $9.69 $9.83 1 168 460
Mar 31, 2023 $9.55 $10.03 $9.35 $9.93 1 671 214
Mar 30, 2023 $9.45 $9.68 $9.18 $9.50 887 948
Mar 29, 2023 $9.19 $9.53 $9.13 $9.45 1 070 468
Mar 28, 2023 $8.98 $9.28 $8.86 $9.15 1 534 616
Mar 27, 2023 $9.00 $9.13 $8.41 $9.00 1 529 003
Mar 24, 2023 $9.01 $9.12 $8.65 $9.03 1 508 229
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT